Progressive Care Inc. Announces Strongest
February
in
Company History
MIAMI,
FL -- March
21,
2019 -- InvestorsHub NewsWire -- Progressive
Care Inc. (OTCQB:
RXMD),
a personalized healthcare services and technology company, today
announced further growth year-over-year in revenue and number of
prescriptions filled for February
2019.
In
February,
the company reported a total of $1.7 million in net revenue,
a 17%
increase from the same month last year, and a 36%
increase in prescriptions filled during the same month last year,
totaling nearly 26,719
prescriptions
filled. Despite industry headwinds through reimbursement
compression, network restriction, and formulary reduction, the
Company continues its upward growth trend for revenues and
prescriptions filled. The Company credits this growth to superior
performance reviews and promotion of value-added
healthcare
service offerings.
"February
was another big
month for us. Progressive Care exceeded February,
2018 prescription fillings and is
moving forward on major initiatives," said S. Parikh Mars, CEO of
Progressive Care. "We are currently
wrapping
up the annual
report and working through the acquisition
process with
licensing and contracting agencies. We are on track to double our
revenues post acquisition of FPRX and are confident that 2019 will
lead to continued growth, more record-breaking months, and even
bigger milestones as we continue our mission to
revolutionize the pharmacy industry."
For
more information about Progressive Care, please visit the
company's website.
Connect and stay in touch
with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive
Care Inc. (OTCQB: RXMD), through its
PharmCo, LLC, is a South Florida health services organization and
provider of prescription pharmaceuticals, compounded medications,
provider of tele-pharmacy services, the sale of anti-retroviral
medications, medication therapy management (MTM), the supply of
prescription medications to long-term care facilities, and health
practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company's
expectations about its future operating results, performance, and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding
the intended terms of the offering, closing of the offering and use
of any proceeds from the offering. When used herein, the words
"anticipate," "believe," "estimate," "upcoming," "plan," "target,"
"intend" and "expect" and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Investor Relations Contact:
Armen
Karapetyan, Progressive Care
Senior
Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations Contact:
Kathleen
Gonzales, CMW Media
Kathleen@cmwmedia.com
www.cmwmedia.com
Web and Application Development Contact:
Marcello
Jaspan, Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com